Cerebral Blood Flow Measured with 3D Pseudocontinuous Arterial Spin-labeling MR Imaging in Alzheimer Disease and Mild Cognitive Impairment: A Marker for Disease Severity
Maja Binnewijzend(Amsterdam UMC Location VUmc), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Wiesje M. van der Flier(Amsterdam Neuroscience), Joost P.A. Kuijer(Amsterdam UMC Location VUmc), Bart N.M. van Berckel(Amsterdam Neuroscience), Mike P. Wattjes(Humboldt-Universität zu Berlin), Alle Meije Wink(University of Cambridge), Marije R. Benedictus(Amsterdam UMC Location Vrije Universiteit Amsterdam), Philip Scheltens(Amsterdam University Medical Centers)
Cited by 266
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k